Athira Pharma’s $4 Million Reckoning: A Cautionary Tale of Research Misconduct
When it comes to scientific research, the stakes are high. For Athira Pharma Inc., a biotech firm headquartered in Bothwell, Washington, the fallout from allegations of research misconduct has culminated in a $4 million settlement with the federal government. At the heart of the matter is a breach of trust—both with federal funding agencies and the public—that underscores just how vital transparency is in the pursuit of scientific progress.